This consensus statement highlights the under-recognition and suboptimal treatment of cardiovascular disease in women, advocating for optimized care and support for female interventional cardiologists.
Requires equitable revascularisation and medications for women with CVD; extends evidence into guideline-directed practice change.
Cardiovascular disease (CVD) is the leading cause of mortality in women, yet studies have suggested that it is often under-recognized. Of particular concern is the apparent suboptimal treatment of women in comparison to men, with less revascularisation and use of evidence-based medications. The Women in Innovations group of cardiologists aims to highlight these issues and change perceptions to optimize the treatment of female patients with CVD, to support future research, and to encourage and guide training of female interventional cardiologists.
No takes yet. Share an insight, caveat, or question.
Chieffo et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: